Ticho Barry, Chief Medical Officer at Stoke Therapeutics ($STOK), sold $1.25 million worth of shares in 23 open market transactions over the past year. His latest sale was on December 5, 2025. These activities rank him 4,427th among 11,678 insiders by total sales value, well below the average of $8.59 million per insider and 6.4 transactions. Barry recorded no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 1838 | $32.66 | 38,864.0000 | 60,397,681 | 4.52% | 0.00% |
| March 18, 2026 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 103 | $32.85 | 40,798.0000 | 60,397,681 | 0.25% | 0.00% |
| March 19, 2026 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Common Stock | 1365 | $2.19 | 42,163.0000 | 60,397,681 | 3.35% | 0.00% |
| March 19, 2026 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 1461 | $29.99 | 40,702.0000 | 60,397,681 | 3.47% | 0.00% |
| March 19, 2026 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 1365 | $0.00 | 83,035.0000 | 60,397,681 | 1.62% | 0.00% |
| March 17, 2026 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 3577 | $32.74 | 50,071.0000 | 60,397,681 | 6.67% | 0.01% |
| March 17, 2026 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 2587 | $33.38 | 47,484.0000 | 60,397,681 | 5.17% | 0.00% |
| March 18, 2026 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 483 | $31.79 | 40,901.0000 | 60,397,681 | 1.17% | 0.00% |
| March 18, 2026 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 6100 | $31.28 | 41,384.0000 | 60,397,681 | 12.85% | 0.01% |
| March 15, 2026 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Restricted Stock Units | 13100 | $0.00 | 13,100.0000 | 60,397,681 | 50.00% | 0.02% |
| March 15, 2026 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Common Stock | 10750 | $0.00 | 53,648.0000 | 60,397,681 | 25.06% | 0.02% |
| March 15, 2026 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Common Stock | 10000 | $0.00 | 42,898.0000 | 60,397,681 | 30.40% | 0.02% |
| March 15, 2026 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Common Stock | 13100 | $0.00 | 32,898.0000 | 60,397,681 | 66.17% | 0.02% |
| March 15, 2026 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Restricted Stock Units | 10000 | $0.00 | 20,000.0000 | 60,397,681 | 33.33% | 0.02% |
| March 15, 2026 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Restricted Stock Units | 10750 | $0.00 | 32,250.0000 | 60,397,681 | 25.00% | 0.02% |
| Feb. 17, 2026 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | A | Restricted Stock Units | 40000 | $0.00 | 40,000.0000 | 60,397,681 | 9999.99% | 0.07% |
| Feb. 17, 2026 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | A | Employee Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 60,397,681 | 9999.99% | 0.10% |
| Dec. 3, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Performance Stock Units | 10000 | $0.00 | 0.0000 | 60,397,681 | 100.00% | 0.02% |
| Dec. 5, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 1989 | $31.35 | 19,798.0000 | 60,397,681 | 9.13% | 0.00% |
| Dec. 5, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 1673 | $31.33 | 21,787.0000 | 60,397,681 | 7.13% | 0.00% |
| Dec. 4, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 323 | $31.32 | 23,460.0000 | 60,397,681 | 1.36% | 0.00% |
| Dec. 4, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 1373 | $30.76 | 23,783.0000 | 60,397,681 | 5.46% | 0.00% |
| Dec. 3, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Common Stock | 10000 | $0.00 | 25,156.0000 | 60,397,681 | 65.98% | 0.02% |
| Dec. 1, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Restricted Stock Units | 11981 | $0.00 | 0.0000 | 60,397,681 | 100.00% | 0.02% |
| Dec. 3, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 1225 | $30.85 | 15,156.0000 | 60,397,681 | 7.48% | 0.00% |
| Dec. 3, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 789 | $30.34 | 16,381.0000 | 60,397,681 | 4.60% | 0.00% |
| Dec. 2, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 762 | $30.14 | 17,170.0000 | 60,397,681 | 4.25% | 0.00% |
| Dec. 2, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 1244 | $29.56 | 17,932.0000 | 60,397,681 | 6.49% | 0.00% |
| Dec. 1, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Common Stock | 11981 | $0.00 | 19,176.0000 | 60,397,681 | 166.52% | 0.02% |
| Nov. 3, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 100 | $29.35 | 7,195.0000 | 60,397,681 | 1.37% | 0.00% |
| Nov. 3, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 600 | $27.54 | 7,295.0000 | 60,397,681 | 7.60% | 0.00% |
| Nov. 3, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 1455 | $26.02 | 7,895.0000 | 60,397,681 | 15.56% | 0.00% |
| Nov. 3, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 3776 | $25.22 | 9,350.0000 | 60,397,681 | 28.77% | 0.01% |
| Oct. 1, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 5343 | $23.64 | 13,126.0000 | 60,397,681 | 28.93% | 0.01% |
| Sept. 2, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 5501 | $19.87 | 18,469.0000 | 54,008,883 | 22.95% | 0.01% |
| Aug. 18, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 2805 | $18.24 | 23,970.0000 | 54,008,883 | 10.48% | 0.01% |
| Aug. 14, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Performance Stock Units | 10000 | $0.00 | 10,000.0000 | 54,008,883 | 50.00% | 0.02% |
| Aug. 14, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | A | Performance Stock Units | 20000 | $0.00 | 20,000.0000 | 54,008,883 | 9999.99% | 0.04% |
| Aug. 14, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Common Stock | 10000 | $0.00 | 26,775.0000 | 54,008,883 | 59.61% | 0.02% |
| Aug. 1, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 4504 | $12.82 | 16,775.0000 | 54,008,883 | 21.17% | 0.01% |
| July 1, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 4503 | $11.63 | 21,279.0000 | 54,008,883 | 17.47% | 0.01% |
| June 3, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 6471 | $10.03 | 25,782.0000 | 54,008,883 | 20.06% | 0.01% |
| June 2, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 1745 | $10.00 | 32,253.0000 | 54,008,883 | 5.13% | 0.00% |
| May 1, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 3841 | $10.00 | 56,788.0000 | 54,008,883 | 6.34% | 0.01% |
| May 2, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 22790 | $10.03 | 33,998.0000 | 54,008,883 | 40.13% | 0.04% |
| March 20, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | A | Employee Stock Option (Right to Buy) | 64000 | $0.00 | 64,000.0000 | 54,008,883 | 9999.99% | 0.12% |
| March 18, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 3884 | $8.67 | 63,962.0000 | 54,008,883 | 5.72% | 0.01% |
| March 19, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 3333 | $8.27 | 60,629.0000 | 54,008,883 | 5.21% | 0.01% |
| March 20, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | A | Restricted Stock Units | 43000 | $0.00 | 43,000.0000 | 54,008,883 | 9999.99% | 0.08% |
| March 15, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Common Stock | 10000 | $0.00 | 67,846.0000 | 54,008,883 | 17.29% | 0.02% |
| March 15, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Restricted Stock Units | 13100 | $0.00 | 26,200.0000 | 54,008,883 | 33.33% | 0.02% |
| March 15, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Restricted Stock Units | 10000 | $0.00 | 30,000.0000 | 54,008,883 | 25.00% | 0.02% |
| March 15, 2025 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Common Stock | 13100 | $0.00 | 57,846.0000 | 54,008,883 | 29.28% | 0.02% |
| Dec. 9, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 2586 | $12.99 | 44,746.0000 | 56,341,074 | 5.46% | 0.00% |
| Dec. 6, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 13945 | $12.78 | 47,332.0000 | 56,341,074 | 22.76% | 0.02% |
| Dec. 3, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Performance Stock Units | 10000 | $0.00 | 10,000.0000 | 56,341,074 | 50.00% | 0.02% |
| Dec. 3, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Common Stock | 10000 | $0.00 | 61,277.0000 | 56,341,074 | 19.50% | 0.02% |
| Dec. 3, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | A | Performance Stock Units | 20000 | $0.00 | 20,000.0000 | 56,341,074 | 9999.99% | 0.04% |
| Dec. 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit (RSU) | 48792 | $0.00 | 11,981.0000 | 56,341,074 | 80.29% | 0.09% |
| Dec. 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Common Stock | 48792 | $0.00 | 51,277.0000 | 56,341,074 | 1963.46% | 0.09% |
| Dec. 2, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Common Stock | 10000 | $0.60 | 61,277.0000 | 56,341,074 | 19.50% | 0.02% |
| Dec. 2, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 10000 | $12.07 | 51,277.0000 | 56,341,074 | 16.32% | 0.02% |
| Dec. 2, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 10000 | $0.00 | 0.0000 | 56,341,074 | 100.00% | 0.02% |
| Nov. 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 10000 | $12.68 | 2,485.0000 | 56,341,074 | 80.10% | 0.02% |
| Nov. 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Common Stock | 10000 | $0.60 | 12,485.0000 | 56,341,074 | 402.41% | 0.02% |
| Nov. 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 56,341,074 | 50.00% | 0.02% |
| Oct. 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 10000 | $12.06 | 2,485.0000 | 56,341,074 | 80.10% | 0.02% |
| Oct. 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Common Stock | 10000 | $0.60 | 12,485.0000 | 56,341,074 | 402.41% | 0.02% |
| Oct. 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 10000 | $0.00 | 20,000.0000 | 56,341,074 | 33.33% | 0.02% |
| Sept. 3, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Common Stock | 10000 | $0.60 | 12,485.0000 | 43,994,862 | 402.41% | 0.02% |
| Sept. 3, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 600 | $15.41 | 2,485.0000 | 43,994,862 | 19.45% | 0.00% |
| Sept. 3, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 10000 | $0.00 | 30,000.0000 | 43,994,862 | 25.00% | 0.02% |
| Sept. 3, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 9400 | $14.92 | 3,085.0000 | 43,994,862 | 75.29% | 0.02% |
| Aug. 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Common Stock | 10000 | $0.60 | 12,485.0000 | 43,994,862 | 402.41% | 0.02% |
| Aug. 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 10000 | $0.00 | 40,000.0000 | 43,994,862 | 20.00% | 0.02% |
| Aug. 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 10000 | $14.58 | 2,485.0000 | 43,994,862 | 80.10% | 0.02% |
| July 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Common Stock | 10000 | $0.60 | 12,485.0000 | 43,994,862 | 402.41% | 0.02% |
| July 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 10000 | $13.75 | 2,485.0000 | 43,994,862 | 80.10% | 0.02% |
| July 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 10000 | $0.00 | 50,000.0000 | 43,994,862 | 16.67% | 0.02% |
| March 27, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | A | Restricted Stock Units | 40000 | $0.00 | 40,000.0000 | 43,994,862 | 9999.99% | 0.09% |
| March 27, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | A | Employee Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 43,994,862 | 9999.99% | 0.14% |
| June 3, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 103 | $15.78 | 2,485.0000 | 43,994,862 | 3.98% | 0.00% |
| June 3, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Common Stock | 10000 | $0.60 | 12,485.0000 | 43,994,862 | 402.41% | 0.02% |
| June 3, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 9897 | $15.21 | 2,588.0000 | 43,994,862 | 79.27% | 0.02% |
| June 3, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 10000 | $0.00 | 60,000.0000 | 43,994,862 | 14.29% | 0.02% |
| May 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Common Stock | 10000 | $0.60 | 12,485.0000 | 43,994,862 | 402.41% | 0.02% |
| May 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 10000 | $0.00 | 70,000.0000 | 43,994,862 | 12.50% | 0.02% |
| May 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 10000 | $11.37 | 2,485.0000 | 43,994,862 | 80.10% | 0.02% |
| April 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 9426 | $13.23 | 2,485.0000 | 43,994,862 | 79.14% | 0.02% |
| April 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Common Stock | 442 | $0.60 | 11,911.0000 | 43,994,862 | 3.85% | 0.00% |
| April 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 442 | $0.00 | 80,000.0000 | 43,994,862 | 0.55% | 0.00% |
| March 15, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Restricted Stock Units | 13100 | $0.00 | 39,300.0000 | 43,994,862 | 25.00% | 0.03% |
| March 19, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 4116 | $6.10 | 11,469.0000 | 43,994,862 | 26.41% | 0.01% |
| March 15, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Common Stock | 13100 | $0.00 | 15,585.0000 | 43,994,862 | 527.16% | 0.03% |
| March 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 5504 | $0.00 | 80,442.0000 | 43,994,862 | 6.40% | 0.01% |
| March 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | M | Common Stock | 5504 | $0.60 | 12,485.0000 | 43,994,862 | 78.84% | 0.01% |
| March 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 10000 | $7.75 | 2,485.0000 | 43,994,862 | 80.10% | 0.02% |
| Feb. 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | CHIEF MEDICAL OFFICER | S | Common Stock | 10000 | $4.80 | 6,981.0000 | 43,994,862 | 58.89% | 0.02% |
| Jan. 2, 2024 | Stoke Therapeutics, Inc. | $STOK | Ticho Barry | Chief Medical Officer | S | Common Stock | 10000 | $5.74 | 16,981.0000 | 43,994,862 | 37.06% | 0.02% |